
Following pledges from Lilly and J&J, Novartis unveils $23B US investment to beef up manufacturing, R&D
On the heels of similar investment pledges from Eli Lilly and Johnson & Johnson, Switzerland’s Novartis is stepping up to the plate with a major plan to grow its U.S. footprint. Novartis will spend $23 billion to build and expand 10 U.S. facilities …